Form 3 - Initial statement of beneficial ownership of securities

S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Form 3 - Initial statement of beneficial ownership of securities

AtriCure (NASDAQ:ATRC)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more AtriCure Charts.

AtriCure (NASDAQ:ATRC)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more AtriCure Charts.

AtriCure Inc News

AtriCure to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Monday 23 December 2024 (2 weeks ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 12 December 2024 (3 weeks ago) • Edgar (US Regulatory)

AtriCure to Participate in the Piper Sandler 36th Annual Healthcare Conference
Wednesday 20 November 2024 (2 months ago) • Business Wire

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

AtriCure to Participate in the Stifel 2024 Healthcare Conference
Thursday 7 November 2024 (2 months ago) • Business Wire

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 30 October 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 29 October 2024 (2 months ago) • Edgar (US Regulatory)

AtriCure Reports Third Quarter 2024 Financial Results
Tuesday 29 October 2024 (2 months ago) • Business Wire

AtriCure to Participate in the UBS Global Healthcare Conference
Monday 28 October 2024 (2 months ago) • Business Wire

AtriCure Announces Launch of cryoSPHERE MAX™ Probe for Post-Operative Pain Management
Tuesday 15 October 2024 (3 months ago) • Business Wire

AtriCure to Announce Third Quarter 2024 Financial Results
Tuesday 8 October 2024 (3 months ago) • Business Wire

AtriCure a obtenu la certification de marquage CE pour la pince EnCompass®
Tuesday 1 October 2024 (3 months ago) • Business Wire

More AtriCure Inc News Articles

Global Developments (PK)

Anavex Life Sciences

Rennova Health (CE)

Northwest Biotherapeutics (QB)

Elite Pharmaceuticals (QB)

Lightwave Logic

Fannie Mae (QB)

Decentral Life (PK)

Digital Brand Media and ... (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions